Bullboard Post History

Order by:

IMVIQ	RE:DPX-Survivac as Monotherapy For Recurring Ovarian Cancer What that "clinical marker" is? "...a subpopulation of... November 20, 2018
IMVIQ	RE:On the Host Earnings Call today Actually it is announced for the 14.12.2018 at a Poster Display session (ID 9... November 2, 2018
IMVIQ	On the Host Earnings Call today Answering to the last questions, it was stated that: a) The data of the... November 2, 2018
IMVIQ	RE:Bio Investor presentation new INFO In Slide 16 it is stated: - Top line Phase 2 Clinical Results with Merck in... October 18, 2018
IMVIQ	Much better than the preliminary with Epacadostat (Ovarian) IMV Inc. Announces Early Positive Results from Phase 2 Clinical Trial of Lead... September 18, 2018
IMVIQ	RE:RE:RE:RE:RE:RE:RE:RE:A partner this year? It is possible! At 15:55-16:05 is said that the timeline already announced (preliminary... August 8, 2018
IMVIQ	RE:RE:RE:Am I wrong? Hi, PoorOpinion: What you say does completely make sense. Just one of the... May 17, 2018
IMVIQ	Am I wrong? Fourteen subjects were enrolled in the initial dose cohort (E 100 mg BID), 10... May 16, 2018